These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2873479)

  • 1. Cushing's syndrome, topical steroids, and cling film.
    Fairris GM; White JE; Tymms DJ; Leatherdale BA
    Lancet; 1986 Jul; 2(8500):228. PubMed ID: 2873479
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent topical steroids and psoriasis.
    Sandoval Cruz M; Moncada B
    J Am Acad Dermatol; 1988 Feb; 18(2 Pt 1):387. PubMed ID: 3346427
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal iatrogenic Cushing's syndrome.
    Nathan AW; Rose GL
    Lancet; 1979 Jan; 1(8109):207. PubMed ID: 84219
    [No Abstract]   [Full Text] [Related]  

  • 4. Iatrogenic Cushing's syndrome--a cautionary tale.
    Lawlor F; Ramabala K
    Clin Exp Dermatol; 1984 May; 9(3):286-9. PubMed ID: 6329563
    [No Abstract]   [Full Text] [Related]  

  • 5. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM; Blanken R; De Heide LJ
    Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cushing's syndrome induced by high-potency topical corticosteroids.
    Demirsoy EO; Bilen N; Aktürk AS; Kocaoğlu Ö; Mutlu GY
    Int J Dermatol; 2014 Jan; 53(1):e20-2. PubMed ID: 22591336
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythrodermic psoriasis associated with hyperuricemia and Iatrogenic Cushing's syndrome due to topical corticosteroid therapy.
    Ohnishi T; Suzuki T; Watanabe S; Takahashi H
    Int J Dermatol; 1996 May; 35(5):379-80. PubMed ID: 8734668
    [No Abstract]   [Full Text] [Related]  

  • 8. Cushing's syndrome secondary to topical corticosteroids abuse.
    Ermis B; Ors R; Tastekin A; Ozkan B
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):795-6. PubMed ID: 12780758
    [No Abstract]   [Full Text] [Related]  

  • 9. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
    Cherian MP; AbdulJabbar M
    Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential hazards of topical steroid therapy.
    Stoppoloni G; Prisco F; Santinelli R; Sicuranza G; Giordano C
    Am J Dis Child; 1983 Nov; 137(11):1130-1. PubMed ID: 6637925
    [No Abstract]   [Full Text] [Related]  

  • 11. Adult iatrogenic Cushing's syndrome induced by topical skin corticosteroid misuse.
    Negrini S; Murdaca G; Ferone D; Borro M
    Therapie; 2019 Oct; 74(5):547-549. PubMed ID: 31023618
    [No Abstract]   [Full Text] [Related]  

  • 12. Clobetasol propionate ointment 0.05% versus diflorasone diacetate ointment 0.05% in moderate to severe psoriasis.
    Jegasothy BV
    Int J Dermatol; 1990 Dec; 29(10):729-30. PubMed ID: 2269571
    [No Abstract]   [Full Text] [Related]  

  • 13. Clobetasol propionate ointment once daily versus fluocinonide ointment three times daily in psoriasis.
    Bickers D; Cornell R; Kamm AR; Bauman WE; Handler RM; Medansky RS; Sturm HM
    Int J Dermatol; 1988; 27(1):54-5. PubMed ID: 3278991
    [No Abstract]   [Full Text] [Related]  

  • 14. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 15. Intermittent topical treatment of psoriasis with clobetasol propionate ("Dermovate").
    Svartholm H; Larsson L; Frederiksen B
    Curr Med Res Opin; 1982; 8(3):154-7. PubMed ID: 6751703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobetasol--a potent new topical corticosteroid.
    Med Lett Drugs Ther; 1986 Jun; 28(715):57-9. PubMed ID: 3520267
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of clobetasol propionate 0.05 percent ointment and an optimized betamethasone dipropionate 0.05 percent ointment in the treatment of psoriasis.
    Jacobson C; Cornell RC; Savin RC
    Cutis; 1986 Mar; 37(3):213-4, 216, 218-20. PubMed ID: 3514155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations.
    Gilbertson EO; Spellman MC; Piacquadio DJ; Mulford MI
    J Am Acad Dermatol; 1998 Feb; 38(2 Pt 2):318-21. PubMed ID: 9486706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized pustular psoriasis associated with withdrawal of topical clobetasol-17-propionate.
    Telfer NR; Dawber RP
    J Am Acad Dermatol; 1987 Jul; 17(1):144-5. PubMed ID: 3611449
    [No Abstract]   [Full Text] [Related]  

  • 20. Cushing's syndrome from topical glucocorticoids.
    Teelucksingh S; Bahall M; Coomansingh D; Suite M; Bartholomew C
    West Indian Med J; 1993 Jun; 42(2):77-8. PubMed ID: 8367969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.